ArGEN-X pairs up with Leo Pharma in a $116M dermatology deal

Damian Garde The antibody experts at arGEN-X have teamed up with dermatology-focused biotech Leo Pharma on a treatment for inflammatory skin diseases, inking a deal worth up to $ 116 ...

Valeant CEO touts R&D output with new dermatology approval

Carly Helfand Less than two weeks after losing longtime acquisition target Allergan–which happily sold itself to Actavis to dodge Valeant's hostile bid and the R&D cuts ...

Corporate VCs back $49M round for dermatology player

John Carroll Novo Ventures has stepped up to lead a $ 49 million round for San Diego-based Thesan Pharmaceuticals, which is developing new dermatology drugs for conditions like acne ...

Dermira scores $35M venture round for dermatology pipeline

John Carroll Less than 2 years after grabbing a $ 42 million A round, Dermira's team of biotech veterans has gone back to the venture well for $ 35 million more to advance a slate ...

Most-recognized dermatology brands, June 2013

chris.truelove by Joshua Slatko (joshua.slatko@ubm.com) The most-recognized dermatology brand in North America is Retin-A. The brand was most-recognized by 6.5 percent of physicians ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS